SS-31 (Elamipretide) 2026 Guide: TAZPOWER Trial Data, Mechanism & Dosage Ranges

SS-31 (elamipretide) is the first mitochondria-targeted peptide to reach FDA approval. Here's what the TAZPOWER, PROGRESS-HF, and HFpEF trial data actually show — plus dosage ranges and how it compares to MOTS-c and NAD+.